Parallax Volatility Advisers, L.P. Nuvalent, Inc. Call Options Transaction History
Parallax Volatility Advisers, L.P.
- $49.8 Billion
- Q4 2024
Call Options
1 transactions
Others Institutions Holding NUVL
# of Institutions
231Shares Held
58.9MCall Options Held
834KPut Options Held
490K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.43 Billion34.87% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.36MShares$426 Million16.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.5MShares$358 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$240 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.62MShares$208 Million6.84% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.42B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...